Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Roche and biosecurity buck the trend

This article was originally published in Clinica

Executive Summary

The latest quarterly results from the diagnostics and device sector reflect the overall sluggishness of the world economy. However, Roche continued to show healthy growth. At the other end of the scale, in the devices sector, the far smaller Meridian Medical Technologies' auto-injector system for nerve agent antidotes enabled it to cash in on the hot biosecurity market, with US and foreign government purchases from the company rising by almost 75%.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts